Journal of nuclear medicine : official publication, Society of Nuclear Medicine | Department of Pediatrics

124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma.

Read more about 124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma.

Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.

Read more about Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.

Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.

Read more about Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.

Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.

Read more about Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.

Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.

Read more about Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with (131)I-MIBG.

Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus.

Read more about Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus.

Subscribe to Journal of nuclear medicine : official publication, Society of Nuclear Medicine